Findings suggest that the complement system plays a role in the onset of acute kidney injury in critically ill patients. Urinary Ba, a fragment of complement factor B, may be a biomarker and ...

The University of Alabama at Birmingham (UAB) is hosting the Renal Symposium. This symposium is focused on acute kidney injury, renal cystic disease, and therapeutics development. An outstanding ...

Opaganib is under clinical development by RedHill Biopharma and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.